Have a personal or library account? Click to login
Fat graft – the natural choice for reconstructive, regenerative and aesthetic surgery Cover

Fat graft – the natural choice for reconstructive, regenerative and aesthetic surgery

Open Access
|Oct 2017

References

  1. 1. O’Neill AC, Zhong T, Hofer SOP. Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists. Ann Surg Oncol. 2017; doi: 10.1245/s10434-017-6014-0.10.1245/s10434-017-6014-028762113
  2. 2. Lourith N, Kanlayavattanakul M. Biopolymeric agents for skin wrinkle treatment. J Cosmet Laser Ther. 2016;18(5):301.10.3109/14764172.2016.115736926963365
  3. 3. Lee SK, Kim HS. Correction of horizontal neck lines: Our preliminary experience with hyaluronic acid fillers. J Cosmet Dermatol. 2017; doi: 10.1111/jocd.12382.10.1111/jocd.1238228726351
  4. 4. Peters W, Fornasier V. Complications from injectable materials used for breast augmentation. Can J Plast Surg. 2009;17(3):89.10.1177/229255030901700305274060320808751
  5. 5. Lee J II, Kang SJ, Sun H. Skin Necrosis with Oculomotor Nerve Palsy Due to a Hyaluronic Acid Filler Injection. Arch Plast Surg. 2017;44:340.10.5999/aps.2017.44.4.340553305628728332
  6. 6. Lafaille P, Benedetto A. Fillers: contraindications, side effects and precautions. J Cutan Aesthet Surg. 2010;3(1):16.10.4103/0974-2077.63222289012920606987
  7. 7. Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: Review. Dermatol Surg. 2005;31:1616.10.2310/6350.2005.31250
  8. 8. Duffy DM. Complications of fillers: overview. Dermatol Surg. 2005; 31(11 Pt 2):1626.10.2310/6350.2005.3125116416648
  9. 9. Saththianathan M, Johani K, Taylor A, Hu H, Vickery K, Callan P, Deva AK. The Role of Bacterial Biofilm in Adverse Soft-Tissue Filler Reactions: A Combined Laboratory and Clinical Study. Plast Reconstr Surg. 2017;139(3):613.10.1097/PRS.000000000000306728234833
  10. 10. Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg. 2008;34:S92.10.1097/00042728-200806001-00020
  11. 11. Stolman LP. Human collagen reactions. Dermatol Surg. 2005;31:1634.10.2310/6350.2005.31252
  12. 12. Mest DR, Humble G. Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience. Dermatol Surg. 2006;32:1336.
  13. 13. Glaisch A, Cohen J, Goldberg L. Injection necrosis of the glabella: Protocol for prevention and treatment after use of dermal fillers. Dermatol Surg. 2006; 32: 276.10.1097/00042728-200602000-00024
  14. 14. Emer J, Waldorf H. Injectable neurotoxins and fillers: There is no free lunch. Clin Dermat. 2011; 29: 678.10.1016/j.clindermatol.2011.08.005
  15. 15. Yanyun C, Wenying W, Jipeng L, Yajie L, Lin L, Ning L. Fundus artery occlusion caused by cosmetic facial injections. Chinese Med J. 2014; 127: 1434.
  16. 16. 2016 Plastic Surgery Statistics Report. www.plasticsurgery.org
  17. 17. Gir P, Brown SA, Oni G, Kashefi N, Mojallal A, Rohrich RJ. Fat grafting: evidence-based review on autologous fat harvesting, processing, reinjection, and storage. Plast Reconstr Surg. 2012;130(1):249.10.1097/PRS.0b013e318254b4d3
  18. 18. Neuber G. Űber die Wiederanheilung vollständig vom Körper getrennter, die ganze Fettschicht enthaltender Hautstücke. Zbl f Chir. 1893;30:16.
  19. 19. Czerny V. Drei plastische Operationen. III. Plastischer Ersatz der Brustdrüse durch ein Lipom. Arch F Klin Chir. 1895;50:544.
  20. 20. Holländer E. Űber einen Fall von fortschreitenden Schwund des Fettgewebes und seinen kosmetischen Ersatz durch Menschenfett. Münch Med Wochenschr. 1910;57:1794.
  21. 21. Lexer E. Die freien Transplantationen. Stuttgart (Germany):Enke; 1919-1924.
  22. 22. Peer LA. Transplantation of tissues. Baltimore (MD): Williams & Wilkins; 1955.
  23. 23. Coleman SR. The technique of periorbital lipoinfiltration. Oper Techn Plast Surg. 1994;1:120.10.1016/S1071-0949(10)80002-2
  24. 24. Coleman SR. Long-term survival of fat transplants: controlled demonstrations. Aesthetic Plast Surg. 1995;19:421.10.1007/BF004538758526158
  25. 25. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211.10.1089/10763270130006285911304456
  26. 26. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS. et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3(3):301.10.1016/j.stem.2008.07.00318786417
  27. 27. Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013; 15(6):641.10.1016/j.jcyt.2013.02.006397943523570660
  28. 28. Aust L, Devlin B, Foster SJ, Halvorsen YD, Hicok K, du Laney T et al. Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy. 2004;6:7.10.1080/1465324031000453914985162
  29. 29. Zhu Y, Liu T, Song K, Fan X, Ma X, Cui Z. Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct 2008;26:664.10.1002/cbf.148818636461
  30. 30. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143.10.1126/science.284.5411.14310102814
  31. 31. Katsha AM, Ohkouchi S, Xin H, Kanehira M, Sun R, Nukiwa T et al. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther. 2011;19(1):196.10.1038/mt.2010.192301743720842104
  32. 32. Shigemura N, Okumura M, Mizuno S, Imanishi Y, Nakamura T, Sawa Y. Autologous transplantation of adipose tissue-derived stromal cells ameliorates pulmonary emphysema. Am J Transplant. 2006;6(11):2592.10.1111/j.1600-6143.2006.01522.x17049053
  33. 33. Palpant NJ, Metzger JM. Aesthetic Cardiology: Adipose-Derived Stem Cells for Myocardial Repair. Curr Stem Cell Res Ther. 2010;5(2):145.10.2174/157488810791268654289601219941452
  34. 34. Cui G-H, Wang YY, Li Ch-J, Shi Ch-H, Wang W-S. Efficacy of mesenchymal stem cells in treating patients with osteoarthritis of the knee: A meta-analysis. Exp Ther Med. 2016;12(5):3390.10.3892/etm.2016.3791510382427882169
  35. 35. Paek HJ, Kim C, Williams SK. Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia. World J Diabetes. 2014;5(3):235.10.4239/wjd.v5.i3.235405872824936245
  36. 36. Siniscalco D, Bradstreet JJ, Sych N, Antonucci N. Mesenchymal stem cells in treating autism: Novel insights. World J Stem Cells. 2014;6(2):173.10.4252/wjsc.v6.i2.173399977524772244
  37. 37. Panes J. Stem Cell Therapy for Perianal Fistulas in Crohn’s Disease. Gastroenterol Hepatol (N Y). 2016;12(10):637.
  38. 38. Stepien A, Dabrowska NL, Maciagowska M, Piusinska-Macoch R, Zolocinska A, Mazur S, et al. Clinical Application of Autologous Adipose Stem Cells in Patients with Multiple Sclerosis: Preliminary Results. Mediators Inflamm. 2016;2016:5302120.10.1155/2016/5302120505957627761060
  39. 39. Choi HS, Kim HJ, Oh JH, Park HG, Ra JC, Chang KA et al. Therapeutic potentials of human adipose-derived stem cells on the mouse model of Parkinson’s disease. Neurobiol Aging. 2015;36(10):2885.10.1016/j.neurobiolaging.2015.06.02226242706
  40. 40. Mead B, Berry M, Logan A, Scott RA, Leadbeater W, Scheven BA. Stem cell treatment of degenerative eye disease. Stem Cell Res. 2015;14(3):243.10.1016/j.scr.2015.02.003443420525752437
  41. 41. Lin G, Wang G, Banie L, Ning H, Shindel AW, Fandel TM et al. Treatment of Stress Urinary Incontinence with Adipose Tissue-Derived Stem Cells. Cytotherapy. 2010;12(1):88.10.3109/14653240903350265287177619878076
  42. 42. Lin JY, Wang C, Pu LL. Can we standardize the techniques for fat grafting? Clin Plast Surg. 2015;42(2):99.10.1016/j.cps.2014.12.00525827564
  43. 43. Cohen SR. Fat Grafting in the Face: Standardization of Harvest, Processing, Cell Enrichment and a New Facial Component Analysis Scale. Plastic Reconstr Surg. 2011; 128(4S): 8.10.1097/01.prs.0000406215.39309.6f
  44. 44. Gabriel A, Champaneria MC, Maxwell GP. Fat grafting and breast reconstruction: tips for ensuring predictability. Gland Surg. 2015;4(3):232.
  45. 45. Padoin AV, Braga-Silva J, Martins P, Rezende K, Rezende AR, Grechi B et al. Sources of processed lipoaspirate cells: influence of donor site on cell concentration. Plast Reconstr Surg. 2008;122:614.10.1097/PRS.0b013e31817d547618626381
  46. 46. Matsumoto D, Sato K, Gonda K, Takaki Y, Shigeura T, Sato T et al. Cell-assisted lipotransfer: supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection. Tissue Eng. 2006;12(12):3375.10.1089/ten.2006.12.337517518674
  47. 47. Yoshimura K, Suga H, Eto H. Adipose-derived stem/progenitor cells: roles in adipose tissue remodeling and potential use for soft tissue augmentation. Regen Med. 2009;4:265.10.2217/17460751.4.2.26519317645
  48. 48. Rohrich RJ, Sorokin ES, Brown SA. In search of improved fat transfer viability: a quantitative analysis of the role of centrifugation and harvest site. Plast Reconstr Surg. 2004; 113(1):391.10.1097/01.PRS.0000097293.56504.0014707664
  49. 49. Small K, Choi M, Petruolo O, Lee C, Karp N. Is there an ideal donor site of fat for secondary breast reconstruction? Aesthet Surg J. 2014;34(4):545.10.1177/1090820X1452675124604787
  50. 50. Moore JH Jr, Kolaczynski JW, Morales LM, Considine RV, Pietrzkowski Z, Noto PF et al. Viability of fat obtained by syringe suction lipectomy: effects of local anesthesia with lidocaine. Aesthetic Plast Surg. 1995;19(4):335.10.1007/BF004516597484471
  51. 51. Kim IH, Yang JD, Lee DG, Chung HY, Cho BC. Evaluation of centrifugation technique and effect of epinephrine on fat cell viability in autologous fat injection. Aesthet Surg J. 2009; 29(1):35.10.1016/j.asj.2008.09.00419233004
  52. 52. Keck M, Zeyda M, Gollinger K, Burjak S, Kamolz LP, Frey M et al. Local anesthetics have a major impact on viability of preadipocytes and their differentiation into adipocytes. Plast Reconstr Surg. 2010;126(5):1500.10.1097/PRS.0b013e3181ef8beb21042106
  53. 53. Khouri RK, Rigotti G, Cardoso E, Khouri RK Jr, Biggs TM. Megavolume autologous fat transfer: part II. Practice and techniques. Plast Reconstr Surg. 2014;133:1369.10.1097/PRS.000000000000017924867720
  54. 54. Cheriyan T, Kao HK, Qiao X, Guo L. Low harvest pressure enhances autologous fat graft viability. Plast Reconstr Surg. 2014; 133(6):1365.10.1097/PRS.000000000000018524867719
  55. 55. Kling RE, Mehrara BJ, Pusic AL, Young VL, Hume KM, Crotty CA et al. Trends in autologous fat grafting to the breast: a national survey of the american society of plastic surgeons. Plast Reconstr Surg. 2013;132(1):35.10.1097/PRS.0b013e318290fad123806907
  56. 56. Ozsoy Z, Kul Z, Bilir A. The role of cannula diameter in improved adipocyte viability: a quantitative analysis. Aesthet Surg J. 2006;26(3):287.10.1016/j.asj.2006.04.00319338908
  57. 57. Erdim M, Tezel E, Numanoglu A, Sav A. The effects of the size of liposuction cannula on adipocyte survival and the optimum temperature for fat graft storage: an experimental study. J Plast Reconstr Aesthet Surg. 2009;62(9):1210.10.1016/j.bjps.2008.03.01618572007
Language: English
Page range: 113 - 117
Submitted on: Aug 29, 2017
|
Accepted on: Sep 7, 2017
|
Published on: Oct 11, 2017
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Samir Ibrahim, Joanna Rybacka-Mossakowska, Sławomir Michalak, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.